Squadron Capital Management provides portfolio management for pooled vehicles. The firm advises 1 private fund.
Squadron Capital Management reports 2 pooled investment vehicles. These counts refer to investment vehicles, rather than the individual investors in them. Of its assets, 100.0% ($386M across 2 accounts) are managed with discretion. Of its clients, 50% are outside the U.S.
| Client type | Clients | Assets |
|---|---|---|
| Pooled investment vehicles | 100% | 100% |
Client breakdown and activity details
| Client type | Clients | Regulatory AUM | AUM share | Avg. per client |
|---|---|---|---|---|
| Pooled investment vehicles | 2 | $386M | 100.0% | $193M |
| Total | 2 | $386M | 100% | $193M |
- Clients
- 2
- Regulatory AUM
- $386M
- AUM share
- 100.0%
- Avg. per client
- $193M
Total
- Clients
- 2
- Regulatory AUM
- $386M
- AUM share
- 100%
- Avg. per client
- $193M
- Clients outside the U.S.
- 50%
- Clients advised without assets under management last fiscal year
- 0
- Private funds advised
- 1
Squadron Capital Management is paid through a percentage of assets under management and performance-based fees; its fees and minimums are set out in its brochures on the SEC website.
It has 4 employees, 3 of them in advisory roles.
Leadership
Staff
- 4 employees
- 3 in advisory functions
- 1 soliciting firm
Besides its headquarters, Squadron Capital Management has 1 office, with 1 listed address in Illinois.
Illinois · 1 listed address
- 1211 West 22nd Street, Suite 1008, Oak BrookHQ
Contact and registration details
- Legal name
- Squadron Capital Management LLC
- Headquarters
- 1211 West 22nd Street, Suite 1008, Oak Brook, IL 60523
- Website
- squadroncapitalmgmt.com
- Phone
- 214-478-3862
- SEC file
- 801-136915
- Structure
- Delaware LLC
- Fiscal year end
- December
Squadron Capital Management has custody of client assets.
Squadron Capital Management’s reported 13F holdings for the quarter ended 30 June 2026 total $322M across 43 positions; the largest are Relmada Therapeutics Inc. (15.8%), C4 Therapeutics Inc. (10.4%) and Cogent Biosciences Inc. (10.4%).
Reported 13F holdings
- $322M
- Reported 13F value
- 43
- Positions
- 66.2%
- In the 10 largest
- +18.1%
- Value vs. prior quarter
- Relmada Therapeutics Inc.15.8%
- C4 Therapeutics Inc. · Com Stk10.4%
- Cogent Biosciences Inc.10.4%
- Kodiak Sciences Inc.6.0%
- Relay Therapeutics Inc.5.6%
- Zentalis Pharmaceuticals Inc.5.6%
- Edgewise Therapeutics Inc.3.7%
- Maze Therapeutics Inc.3.1%
- Inventiva SA · ADS2.9%
- Adlai Nortye Ltd · Sponsored ADS2.7%
Together, the ten largest are 66.2% of reported value.
How many clients does Squadron Capital Management have?
Squadron Capital Management has 2 clients and manages $386 million for them, as of June 2026. They include 2 pooled investment vehicles.
Source: Form ADV Part 1A, Items 5.D and 5.F, filed 29 June 2026
What services does Squadron Capital Management offer?
Squadron Capital Management provides portfolio management for pooled vehicles.
Source: Form ADV Part 1A, Item 5.G, from the SEC's 2 October 2026 data file
How many financial advisors does Squadron Capital Management have?
Squadron Capital Management has 0 investment adviser representatives registered with state securities authorities, out of 4 employees, and 3 perform investment advisory functions. None are registered representatives of a broker-dealer or licensed insurance agents.
Source: Form ADV Part 1A, Items 5.A and 5.B, from the SEC's 2 October 2026 data file
How does Squadron Capital Management get paid?
Squadron Capital Management is paid through a percentage of assets under management and performance-based fees. Its Form ADV lists no commissions among how it is paid.
Source: Form ADV Part 1A, Item 5.E, from the SEC's 2 October 2026 data file
How do I contact Squadron Capital Management?
Squadron Capital Management’s main office is at 1211 West 22nd Street, Suite 1008, Oak Brook, IL 60523. Its phone number is 214-478-3862. Its website is squadroncapitalmgmt.com.